Information Technology


exchange ideas and information related to Information Technology for use in Transfusion Medicine

Information Technology (IT) is a critical part of Transfusion Medicine and Cellular Therapy which comprises recruitment, collection, testing, processing, distribution, transfusion/transplantation and quality. IT supports fast and easy access to process data generated in the blood supply chain, including manufacturing, labelling and inventory, facilitating and improving compliance with Good Manufacturing Practice (GMP). 

Specific goals include:

a. To define and promote strategies on using information technologies for transfusion medicine, cellular therapy, and related areas considering usability, implementation, financial, and business impacts.

b. To evaluate new IT technologies and their applicability to transfusion medicine, cellular therapy, and related areas.

c. To provide education for the membership in Information Technology.


As a member, you have the opportunity to drive forward IT, automated system solutions and standards by sharing experience and knowledge. We discuss the various strategies, IT-related developments and potential new techniques. This WP has four taskforces: Interface, Radio Frequency Identification, Traceability and Validation.

There are currently about 35 active members and 10 active observers in the WPIT. The participation reflects a balanced representation of transfusion medicine/cellular therapy facilities and industry from many countries around the world.

Members of the Executive Committee are:

  • Michael Breard, Chair and Traceability Task Force Chair
  • Goudar Shankar, Vice-Chair
  • Monica Freire, Secretary
  • Jan-Willem Andriessen, Validation Task Force Chair
  • Wayne Bolton, RFID Task Force Chair
  • Linda Lodge, Interface Task Force Chair
  • Ralf Knels, Past Chair
  • Mario Muon, ICCBBA TAG Representative


The WPIT accomplishes its goals through task forces. Currently there are four task forces: Interface Standard, RFID, Traceability, and Validation.

Joining the WP

Full members of the WP will have interest in the WP process and must be active or honorary members of ISBT. Observer status may be afforded to non-members of ISBT for a period of up to 2 years.

Observers may attend and participate in the WP meetings, but may not vote.

The WPIT members should have:

  • Knowledge of the use of IT in the fields of transfusion and transplantation
  • Knowledge of and working in transfusion medicine, cellular therapy, and/or related areas
  • Ability to support ISBT WPIT activities on a volunteer basis (free-of-charge) with their employer’s consent and support
  • Good communication skills

Persons interested in joining the WPIT should contact its Chair

Contact persons for the IT Working Party are Shankar Goudar, Vice President and Mónica Feire, Secretary.


Face-to-face meetings of the WPIT occur annually in conjunction with an ISBT Congress. Additionally, each task force, as well as the full assembly of participants, have regular conference calls.


Some of the content is only accessible for ISBT-members. To join us, click here.


  1. Guidelines for the use of RFID technology in transfusion medicineKnels R, Ashford P, Bidet F, Böcker W, Briggs L, Bruce P, Csöre M, Distler P, Gutierrez A, Henderson I, Hohberger C, Holcombe J, Holmberg J, Hulleman R, Marcel B, Messenger P, Mun I, Roberts S, Sandler G, Veeramani R, Wray B; Vox Sanguinis, April 2010

Interface Taskforce

Consultation on Interface Standard

On behalf of the WPIT Interface Taskforce Steering Group, I would like to thank all those who took time to review the proposals for the ISBT I2B Standard Interface. Special thanks is extended to those who submitted comments and suggestions. The consultation feedback has now been reviewed and the output from that review can be found below.

Given the positivity of the responses the WPIT Interface Taskforce intend to proceed to publication of the interface. In addition to preparing the publication the taskforce will continue to develop the content of the IBT2000 table to include agreed data item definitions for other instrument observations. The up to date content of both the IBT1000 and IBT2000 tables will be displayed on the ISBT website.

Requests to participate in the development of the IBT2000 table entries should be addressed to Linda Lodge or Pat Distler in the first instance. 


Suzanne H. Butch

Suzanne H. Butch


Suzanne H. Butch
Consultant in Laboratory Management